Results from ongoing study suggest the major role of Celartics' Cov-DCVax in preventing viral infection of COVID-19 and in controlling progression of the virus-associated diseasesBeijing, May 22, 2020, Celartics Biopharma announced today the filing of a patent application covering a novel dendritic cell (DC)-based vaccine, Cov-DCVax, to fight viral infection of COVID-19. The results, led by Celart
10 Item Per Halaman (Laman 1 / 1) Jumlah 5 Item
11-19
11-16
11-12
11-11
11-06
11-04
11-04
10-28
10-27
10-26
